DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Riedl JM, Posch F, Horvath L. et al.
Gemcitabine/nab-paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: a propensity score analysis.
Eur J Cancer 2021;
151: 3-13
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.